An air care agent containing at least one compound that acts as an antagonist of the human olfactory ion channel cyclic nucleotide gated channel alpha 2 (CNGA2; NCBI reference sequence: NP_005131.1), wherein the compound that acts as a CNGA2 antagonist is a compound of formula wherein X represents NR1 or O; R1 represents a linear or branched, substituted or unsubstituted alkoxy group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkyl group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkenyl group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkinyl group having 1 to 4 C-atoms; R2, R3, R4, R5, R6 and R7 each represent, independently of one another, hydrogen, a halogen atom, an amino group, -NO 2 -NH-(C 1-4 alkyl), -N(C 1-4 alkyl) 2, a linear or branched, substituted or unsubstituted alkoxy group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkyl group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkenyl group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkinyl group having 1 to 4 C-atoms, -OH or a -C(=O)-Y group; and Y represents -OH, -O(C 1-4 alkyl), -NH 2, NH-(C 1-4 alkyl) or -N(C 1-4 alkyl) 2, wherein the compound that acts as a CNGA2 antagonist is contained in amounts of between 0.0001 and 50 wt.%, advantageously between 0.001 and 5 wt.%, more advantageously between 0.01 and 3 wt.%, in particular between 0.01 and 2 wt.%, based in each case on the entire agent, and the air care agent additionally contains one or more fragrance(s), in particular selected from the group comprising fragrances of natural or synthetic origin, preferably more volatile fragrances, fragrances having higher boiling points, solid fragrances and/or fragrances having good adhesion. X represents NR1 or O; R1 represents a linear or branched, substituted or unsubstituted alkoxy group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkyl group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkenyl group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkinyl group having 1 to 4 C-atoms; R2, R3, R4, R5, R6 and R7 each represent, independently of one another, hydrogen, a halogen atom, an amino group, -NO 2 -NH-(C 1-4 alkyl), -N(C 1-4 alkyl) 2, a linear or branched, substituted or unsubstituted alkoxy group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkyl group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkenyl group having 1 to 4 C-atoms, a linear or branched, substituted or unsubstituted alkinyl group having 1 to 4 C-atoms, -OH or a -C(=O)-Y group; and Y represents -OH, -O(C 1-4 alkyl), -NH 2, NH-(C 1-4 alkyl) or -N(C 1-4 alkyl) 2, wherein the compound that acts as a CNGA2 antagonist is contained in amounts of between 0.0001 and 50 wt.%, advantageously between 0.001 and 5 wt.%, more advantageously between 0.01 and 3 wt.%, in particular between 0.01 and 2 wt.%, based in each case on the entire agent, and the air care agent additionally contains one or more fragrance(s), in particular selected from the group comprising fragrances of natural or synthetic origin, preferably more volatile fragrances, fragrances having higher boiling points, solid fragrances and/or fragrances having good adhesion.